Enclomiphene is a selective estrogen receptor modulator (SERM) primarily used to increase testosterone levels in men. The medication stimulates the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones, in turn, signal the testicles to produce more testosterone. Ceasing enclomiphene use leads to a reduction in LH and FSH secretion, subsequently impacting testicular testosterone production.
Maintaining adequate testosterone levels is vital for several physiological functions, including muscle mass, bone density, libido, and energy levels. For individuals using enclomiphene to address low testosterone, discontinuing its administration can result in a return to pre-treatment testosterone levels, potentially reversing any benefits gained during treatment. Therefore, understanding the implications of stopping the medication is important for managing expectations and exploring alternative treatment strategies.